Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.73 HKD
Change Today -0.01 / -1.35%
Volume 5.7M
As of 4:01 AM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

ck life sciences intl hldgs (775) Snapshot

Open
$0.74
Previous Close
$0.74
Day High
$0.75
Day Low
$0.73
52 Week High
09/22/14 - $0.91
52 Week Low
05/12/14 - $0.71
Market Cap
7.0B
Average Volume 10 Days
6.3M
EPS TTM
$0.03
Shares Outstanding
9.6B
EX-Date
05/20/15
P/E TM
26.6x
Dividend
$0.0080
Dividend Yield
0.96%
Current Stock Chart for CK LIFE SCIENCES INTL HLDGS (775)

Related News

No related news articles were found.

ck life sciences intl hldgs (775) Related Businessweek News

No Related Businessweek News Found

ck life sciences intl hldgs (775) Details

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, is engaged in the research and development, manufacture, commercialization, marketing, and sale of health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products; and contract manufactures complementary healthcare medicines and produces non-sterile prescription and over-the-counter medicines. The company is also involved in licensing registration activities and the importation of finished agricultural goods; holding land and building; financing, water treatment, and trustee activities; investment in financial instruments, as well as vineyards and wineries; trading biotechnology products and nutritional supplements; and the manufacture, wholesale, retail, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as chemicals and professional pest products; produces, refines, and distributes salt products; and provides services in the research and development of bio-technology and life sciences technology products. CK Life Sciences’ products include emulsifiable concentrates, suspension concentrates, aqueous solutions, coated granules, powders, and amination based reactions for crop protection; and pharmaceutical products, such as Tetrodotoxin and POL-103A that are in advanced stages of clinical development, as well as CKBP002 and CKBP004 that are in pre-clinical studies for the treatment of cancer. The company is headquartered in Tai Po, Hong Kong.

1,675 Employees
Last Reported Date: 02/24/15

ck life sciences intl hldgs (775) Top Compensated Officers

Chief Operating Officer, Vice President, Comp...
Total Annual Compensation: $9.1M
Chief Scientific Officer, Vice President and ...
Total Annual Compensation: $6.6M
Compensation as of Fiscal Year 2013.

ck life sciences intl hldgs (775) Key Developments

CK Life Sciences Int'l., (Holdings) Inc. Reports Audited Consolidated Earnings Results for the Year Ended December 31, 2014

CK Life Sciences Int'l., (Holdings) Inc. reported audited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported turnover of HKD 4,954,043,000 compared to HKD 4,970,927,000 reported a year ago. Profit before taxation was HKD 321,130,000 compared to HKD 303,729,000 reported a year ago. Profit attributable to shareholders of the company was HKD 263,558,000 or 2.74 cents per diluted share compared to HKD 229,008,000 or 2.38 cents per diluted share reported a year ago. Purchases of property, plant and equipment were HKD 140,861,000 compared to HKD 139,594,000 reported a year ago. Purchases of investment properties were HKD 210,725,000 compared to HKD 98,865,000 reported a year ago. Purchases of vines were HKD 138,326,000 compared to HKD 47,851,000 reported a year ago. Additions to intangible assets were HKD 5,603,000 compared to HKD 31,109,000 reported a year ago.

CK Life Sciences Int’l., (Holdings) Inc. Appoints Kwan Kai Cheong as Independent Non-Executive Director

The board of directors of CK Life Sciences Int’l., (Holdings) Inc. announced that Mr. Kwan Kai Cheong has been appointed as an Independent Non-executive Director of the Company with effect from 24 March 2015. Mr. Kwan, aged 65, is President of Morrison & Company Limited. He worked for Merrill Lynch & Co. Inc. for over 10 years during the period from 1982 to 1993, with his last position as President for its Asia Pacific region. He was formerly Joint Managing Director of Pacific Concord Holding Limited.

CK Life Sciences Int'l., (Holdings) Inc. Reports Consolidated Earnings Statement for the Year Ended December 31, 2014; Declares Final Dividend for the Year Ended 31 December 2014, Payable on 2 June 2015

CK Life Sciences Int'l., (Holdings) Inc. reported consolidated earnings statement for the year ended December 31, 2014. For the year, the company reported turnover of HKD 4,954,043,000 against HKD 4,970,927,000 a year ago. Profit before taxation was HKD 321,130,000 against HKD 303,729,000 a year ago. Profit for the year was HKD 272,752,000 against HKD 234,546,000 a year ago. Attributable to shareholders of the company was HKD 263,558,000 against HKD 229,008,000 a year ago. Basic and diluted earnings per share were 2.74 cents against 2.38 cents a year ago. The Board of Directors has recommended a final dividend of HKD 0.008 per share for the year ended 31 December 2014 against HKD 0.007 per share in 2013, a 14% increase over the previous year. The proposed dividend will be paid on 2 June 2015 following approval at the 2015 Annual General Meeting to those shareholders whose names appear on the register of members of the company at the close of business on 21 May 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
775:HK $0.73 HKD -0.01

775 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Henderson Land Development Co Ltd $55.85 HKD +1.40
Real Nutriceutical Group Ltd $2.31 HKD +0.09
Tom Group Ltd $2.17 HKD -0.06
View Industry Companies
 

Industry Analysis

775

Industry Average

Valuation 775 Industry Range
Price/Earnings 27.0x
Price/Sales 1.4x
Price/Book 1.5x
Price/Cash Flow 21.5x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CK LIFE SCIENCES INTL HLDGS, please visit www.ck-lifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.